文献速递产科母胎医学

妊娠期冠状病毒谱感染(SARS、MERS、COVID-19)结局的系统综述与荟萃分析

Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis.
PubMed 文献 · Am J Obstet Gynecol MFM · 2020-03-25

该系统综述纳入19项研究共79例住院孕妇,其中COVID-19 41例、MERS 12例、SARS 26例。所有感染中早产<37周合并比例为24.3%,COVID-19中为41.1%;围产期死亡合并比例11.1%,COVID-19中为7.0%;41例评估新生儿均无垂直传播临床证据。

要点

  • 住院孕妇冠状病毒感染中早产是最常见不良结局,COVID-19早产率更高。
  • COVID-19与更高的早产、子痫前期、剖宫产和围产期死亡比例相关。
  • 评估的41例新生儿均无垂直传播临床证据。

核心结论

  • 住院孕妇冠状病毒感染(包括COVID-19)中超过90%合并肺炎,早产是最常见不良妊娠结局。
  • COVID-19感染与更高的早产、子痫前期、剖宫产和围产期死亡比例相关。
  • 已发表病例中无垂直传播的临床证据。

研究设计与样本

  • 系统综述与荟萃分析,检索Medline、Embase、Cinahl和Clinicaltrials.gov,限英文。
  • 纳入19项研究共79例住院孕妇,COVID-19 41例(51.9%)、MERS 12例(15.2%)、SARS 26例(32.9%)。
  • 采用比例荟萃分析合并数据,报告合并比例。

主要发现

  • 肺炎明确诊断占91.8%,常见症状为发热82.6%、咳嗽57.1%、呼吸困难27.0%。
  • 所有冠状病毒感染中,早产<37周合并比例24.3%(14/56,95%CI 12.5-38.6),剖宫产84%(50/58),围产期死亡11.1%(5/60,95%CI 84.8-19.6)。
  • COVID-19中早产<37周占41.1%(14/32,95%CI 25.6-57.6),围产期死亡合并比例7.0%(2/41,95%CI 1.4-16.3)。
  • 41例评估新生儿均无垂直传播临床体征。

关键数值与推荐

  • 纳入标准为住院孕妇且确诊冠状病毒相关疾病(SARS、MERS或COVID-19)。
  • 所有冠状病毒感染中,流产合并比例64.7%(8/12,95%CI 37.9-87.3),仅来自两项SARS研究且无对照组。
  • 所有冠状病毒感染中,未足月胎膜早破20.7%(6/34,95%CI 9.5-34.9),子痫前期16.2%(2/19,95%CI 4.2-34.1),胎儿生长受限11.7%(2/29,95%CI 3.2-24.4),后两者仅报告于SARS。
  • 所有冠状病毒感染中,新生儿重症监护入住率57.2%(3/12,95%CI 3.6-99.8)。

临床怎么用

  • 研究结果可用于指导妊娠期COVID-19感染孕妇的产前咨询。
  • 鉴于纳入病例数极少,解读这些数据时应谨慎。
  • 证据正在快速积累,这些数据可能需要很快更新。

局限性

  • 纳入病例数非常少(共79例)。
  • 部分结局仅报告于SARS且无对照组。
  • 证据快速积累,数据可能需更新。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this systematic review was to report pregnancy and perinatal outcomes of coronavirus spectrum infections, and particularly coronavirus 2019 (COVID-19) disease because of severe acute respiratory syndrome-coronavirus-2 infection during pregnancy. DATA SOURCES: Medline, Embase, Cinahl, and Clinicaltrials.gov databases were searched electronically utilizing combinations of word variants for coronavirus or severe acute respiratory syndrome or SARS or Middle East respiratory syndrome or MERS or COVID-19 and pregnancy. The search and selection criteria were restricted to English language. STUDY ELIGIBILITY CRITERIA: Inclusion criteria were hospitalized pregnant women with a confirmed coronavirus related-illness, defined as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), or COVID-19. STUDY APPRAISAL AND SYNTHESIS METHODS: We used meta-analyses of proportions to combine data and reported pooled proportions, so that a pooled proportion may not coincide with the actual raw proportion in the results. The pregnancy outcomes observed included miscarriage, preterm birth, preeclampsia, preterm prelabor rupture of membranes, fetal growth restriction, and mode of delivery. The perinatal outcomes observed were fetal distress, Apgar score <7 at 5 minutes, neonatal asphyxia, admission to a neonatal intensive care unit, perinatal death, and evidence of vertical transmission. RESULTS: Nineteen studies including 79 hospitalized women were eligible for this systematic review: 41 pregnancies (51.9%) affected by COVID-19, 12 (15.2%) by MERS, and 26 (32.9%) by SARS. An overt diagnosis of pneumonia was made in 91.8%, and the most common symptoms were fever (82.6%), cough (57.1%), and dyspnea (27.0%). For all coronavirus infections, the pooled proportion of miscarriage was 64.7% (8/12; 95% confidence interval, 37.9-87.3), although reported only for women affected by SARS in two studies with no control group; the pooled proportion of preterm birth <37 weeks was 24.3% (14/56; 95% confidence interval, 12.5-38.6); premature prelabor rupture of membranes occurred in 20.7% (6/34; 95% confidence interval, 9.5-34.9), preeclampsia in 16.2% (2/19; 95% confidence interval, 4.2-34.1), and fetal growth restriction in 11.7% (2/29; 95% confidence interval, 3.2-24.4), although reported only for women affected by SARS; 84% (50/58) were delivered by cesarean; the pooled proportion of perinatal death was 11.1% (5/60; 95% confidence interval, 84.8-19.6), and 57.2% of newborns (3/12; 95% confidence interval, 3.6-99.8) were admitted to the neonatal intensive care unit. When focusing on COVID-19, the most common adverse pregnancy outcome was preterm birth <37 weeks, occurring in 41.1% of cases (14/32; 95% confidence interval, 25.6-57.6), while the pooled proportion of perinatal death was 7.0% (2/41; 95% confidence interval, 1.4-16.3). None of the 41 newborns assessed showed clinical signs of vertical transmission. CONCLUSION: In hospitalized mothers infected with coronavirus infections, including COVID-19, >90% of whom also had pneumonia, preterm birth is the most common adverse pregnancy outcome. COVID-19 infection was associated with higher rate (and pooled proportions) of preterm birth, preeclampsia, cesarean, and perinatal death. There have been no published cases of clinical evidence of vertical transmission. Evidence is accumulating rapidly, so these data may need to be updated soon. The findings from this study can guide and enhance prenatal counseling of women with COVID-19 infection occurring during pregnancy, although they should be interpreted with caution in view of the very small number of included cases.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Di Mascio D, Khalil A, Saccone G, et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020. PMID: 32292902. doi:10.1016/j.ajogmf.2020.100107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。